An evaluation of naloxone as a narcotic antagonist in the dog.
D000769:Anesthesia, Inhalation; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D004283:Dog Diseases / Q000601:surgery; D004285:Dogs; D004329:Droperidol / Q000008:administration & dosage; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D006339:Heart Rate / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D009020:Morphine / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D009270:Naloxone / Q000008:administration & dosage / Q000494:pharmacology*; D009458:Neuroleptanalgesia; D009609:Nitrous Oxide; D010100:Oxygen / Q000097:blood
D002245:Carbon Dioxide; D009270:Naloxone; D009020:Morphine; D009609:Nitrous Oxide; D004329:Droperidol; D010100:Oxygen; D005283:Fentanyl